Results

Total Results: 86 records

Showing results for "drug".

1. Drug-drug interaction | CDS Connect
   cds.ahrq.gov/cdsconnect/keywords/drug-drug-interaction
   May 18, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

2. drug | CDS Connect
   cds.ahrq.gov/cdsconnect/keywords/drug
   May 31, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

3. Drug Interactions | CDS Connect
   cds.ahrq.gov/taxonomy/term/44311
   May 18, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

4. Drug Safety | CDS Connect
   cds.ahrq.gov/cdsconnect/keywords/drug-safety
   August 23, 2024 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

5. Prescription Drug Misuse | CDS Connect
   cds.ahrq.gov/cdsconnect/keywords/prescription-drug-misuse
   November 30, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

6. Budesonide, Formoterol Fumarate Drug Combination | CDS Connect
   cds.ahrq.gov/taxonomy/term/5071
   July 30, 2021 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

7. Recommendation #10 - Urine Drug Testing | CDS Connect
   cds.ahrq.gov/cdsconnect/artifact/recommendation-10-urine-drug-testing
   April 23, 2017 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

8. Contextual drug interaction decision support algorithm for warfarin - Nonsteroidal anti-inflammatory drugs (NSAIDs) | CDS Connect
   cds.ahrq.gov/cdsconnect/artifact/contextual-drug-interaction-decision-support-algorithm-warfarin-nonsteroidal
   May 16, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

9. June 2021 CDS Connect Work Group Slides (pdf file)
   cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdf
   January 01, 2021 - 02 - 3:05 • Review of the Agenda, Maria Michaels (CDC) 3:05 - 3:50 • Using CDS to Reduce Harm From Drug-Drug … admissions associated with an adverse drug event attributable to drug-drug interactions:2 ► 22.2% … Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. … Optimizing Drug-Drug Interaction Alerts Using a Multidimensional Approach. … Interaction CDS The Use Case: �Contextualized drug-drug interaction CDS Potential drug-drug interactions

10. Mometasone Furoate, Formoterol Fumarate Drug Combination | CDS Connect
    cds.ahrq.gov/taxonomy/term/3556
    July 30, 2021 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

11. Contextual drug interaction decision support algorithm for warfarin - antidepressants | CDS Connect
    cds.ahrq.gov/cdsconnect/artifact/contextual-drug-interaction-decision-support-algorithm-warfarin-antidepressants
    May 18, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

12. CDS Connect Work Group June 2021 Summary (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
    January 01, 2021 - meeting objectives and agenda • Overview of CDS Connect tools that aim to reduce harm from potential drug-to-drug … The CDS artifact incorporates the complexities of drug and patient characteristics to calculate the … computer screening of electronic health records (EHR), pharmacist screening, patient risk factors, drug … The CDS artifact is a logic model-building tool for use by drug experts who are not versed in FHIR. … implemented, only 6 individuals were alerted to minimize risk, with another 2 advised to avoid the drug

13. Managing chronic pain with Prescription Drug Monitoring Program (PDMP) medication dispense data | CDS Connect
    cds.ahrq.gov/cdsconnect/artifact/managing-chronic-pain-prescription-drug-monitoring-program-pdmp-medication
    November 17, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

14. Pilot Site Training For Pain Management Summary Cds For Repository (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS%20for%20Repository.pdf
    May 24, 2023 - lowest effective dose § Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk § Urine drug … Non-pharmacologic treatments – Stool softeners and laxatives Risk Considerations – MME amount – Urine drug … past 2 years CDS Summary Section: Risk Factors and Assessments § MME amount - most recent § Urine drug … year have you had five or more drinks (men) or four or more drinks (women). 0=none, 1=1 or more – Drug … ” § Urine Drug Screens – Elements: Urine drug screen – Flag if urine drug screen is not present and

15. Warfarin-Antidepressants Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - Population Statements f Table 7: Additional Decisions h Introduction Background Ensuring that drug-drug … pharmacists in applying this artifact toward enhancing clinical decision support (CDS) for potential drug-drug … Providing information to clinicians about drug-drug interaction warnings based on known attributes of … , organizations, and systems to provide useful decision support to reduce patient harm due to these drug-drug … has one or more risk factors for major bleeding based on other pertinent medical history and ongoing drug

16. AHRQ PCOR CDS Project Kickoff (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository.pdf
    September 21, 2018 - lowest effective dose ▪ Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk ▪ Urine drug … Non-pharmacologic treatments – Stool softeners and laxatives Risk Considerations – MME amount – Urine drug … Public Release CDS Summary Section: Risk Factors and Assessments ▪ MME amount - most recent ▪ Urine drug … year have you had five or more drinks (men) or four or more drinks (women). 0=none, 1=1 or more – Drug … ” ▪ Urine Drug Screens – Elements: Urine drug screen – Flag if urine drug screen is not present and

17. AHRQ PCOR CDS Project Kickoff (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
    September 21, 2018 - lowest effective dose ▪ Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk ▪ Urine drug … Non-pharmacologic treatments – Stool softeners and laxatives Risk Considerations – MME amount – Urine drug … Public Release CDS Summary Section: Risk Factors and Assessments ▪ MME amount - most recent ▪ Urine drug … year have you had five or more drinks (men) or four or more drinks (women). 0=none, 1=1 or more – Drug … ” ▪ Urine Drug Screens – Elements: Urine drug screen – Flag if urine drug screen is not present and

18. Alcohol and Other Substance Use Screening Using the National Institute on Drug Abuse Quick Screen (NIDA QS) and USAUDIT (Alcohol Use Disorders Identification Test, Adapted for Use in the United States) | CDS Connect
    cds.ahrq.gov/cdsconnect/artifact/alcohol-and-other-substance-use-screening-using-national-institute-drug-abuse
    June 04, 2020 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

19. CDS Logic Flow: NIDA QS to USAUDIT Alcohol Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1171/Logic_Flow_NIDA_QS_to_USAUDIT_Alcohol_Screening_v2.pdf
    August 05, 2020 - Support (CDS) Logic Flow: Alcohol and Other Substance Use Screening Using the National Institute on Drug … Support (CDS) Logic Flow: Alcohol and Other Substance Use Screening Using the National Institute on Drug

20. Warfarin-Nsaids Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Population Statements f Table 7: Additional Decisions h Introduction Background Ensuring that drug-drug … pharmacists in applying this artifact toward enhancing clinical decision support (CDS) for potential drug-drug … Providing information to clinicians about drug-drug interaction warnings based on known attributes of … , organizations, and systems to provide useful decision support to reduce patient harm due to these drug-drug … Drug factors involved: · Warfarin · NSAIDs · PPIs and Misoprostols Guideline Interpretation and Clinical